RAD21, by exerting a DSB repair function, enables rapid repair of DNA breaks caused by PARP inhibitor treatment, leading to cell survival and thus the resistance of ovarian cancer cells to PARP inhibitors. This evidence concerns the gene RAD21 and ovarian cancer.